Yahoo Web Search

  1. Alector, Inc. ALEC announced the initiation of the phase I INTERCEPT study on AL003 for the treatment of Alzheimer’s disease. ...s disease. AL003 is the company's second product candidate ...

  2. AbbVie (ABBV) Gains But Lags Market: What You Should Know

    Zacks via Yahoo FinanceApr 01 21:45 PM

    This change lagged the S&P 500's 1.16% gain on the day. Heading into today, shares of the drugmaker had gained 1.7% over the past month, outpacing the Medical sector's gain of 1.35% and lagging ...

  3. In that same time, the Medical sector gained 1.2%, while the S&P 500 gained 3.84%. ABBV will be looking to display strength as it nears its next earnings release, which is expected to be April ...

  4. Novartis Resubmits BLA to FDA for Biosimilar of Neulasta

    Zacks via Yahoo FinanceApr 04 13:39 PM

    Novartis AG’s NVS generic arm, Sandoz, resubmitted its Biologics License Application (BLA) for a proposed biosimilar of Neulasta to the FDA. The BLA was resubmitted to the FDA to address the ...

  5. Top Stock Reports for Boeing, Lockheed Martin & Anthem

    Zacks via Yahoo FinanceApr 05 19:37 PM

    Friday, April 5, 2019 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Boeing ...

  6. AbbVie (ABBV) Earnings Expected to Grow: Should You Buy?

    Zacks via Yahoo FinanceApr 18 14:33 PM

    Wall Street expects a year-over-year increase in earnings on lower revenues when AbbVie (ABBV) reports results for the quarter ended March 2019. While this widely-known consensus outlook ...

  7. Johnson & Johnson JNJ stock has risen 5.5% this year so far compared with an increase of 3.7% recorded by the industry. This marks a decent recovery from a decline of 7.3% last year on allegations ...

  8. AbbVie: High-Yield Dividend Aristocrat Offering a No-Fee DRIP

    GuruFocus.com via Yahoo FinanceApr 05 21:08 PM

    Dividend growth investing has proven to be one of the best ways for retail investors to accumulate wealth over the long term. One of the factors that boosts the wealth-creating power of dividend ...

  9. Johnson & Johnson JNJ will report first-quarter 2019 results on Apr 6, before market open. In the last reported quarter, the company delivered a positive earnings surprise of 1.03%. J&J’s performance ...

  10. Analyst Note Fosters Doubts About Dow Inc Stock

    InvestorPlace via Yahoo FinanceApr 10 15:00 PM

    Shares of the now-independent Dow Inc (NYSE:DOW) declined on Friday for the first time since the company was spun off . In his report, he noted that DOW has a higher dividend than its peers.

  1. Ad
    related to Abbvie Inc